This post is from a suggested group
Liquid Biopsy: Transforming the Future of Disease Detection and Personalized Medicine
Liquid biopsy is rapidly emerging as a groundbreaking innovation in modern healthcare, offering a less invasive, faster, and more accurate method to detect and monitor diseases, particularly cancer. Unlike traditional tissue biopsies that require surgical procedures, a liquid biopsy uses a simple blood sample to identify genetic mutations, tumor DNA, or other biomarkers circulating in the bloodstream. This revolutionary approach is transforming how doctors diagnose, treat, and manage complex diseases — paving the way toward truly personalized medicine.
At its core, liquid biopsy enables early detection of cancer by identifying fragments of tumor DNA known as circulating tumor DNA (ctDNA). These tiny genetic fragments provide crucial information about the nature of the tumor — including its genetic mutations, resistance patterns, and progression over time. Since blood samples can be taken more frequently and safely than surgical tissue biopsies, doctors…